Management of Serotonin Syndrome
The management of serotonin syndrome requires immediate discontinuation of all serotonergic agents and prompt supportive care, with benzodiazepines as first-line treatment for agitation and cyproheptadine as the antidote for moderate to severe cases. 1
Diagnosis
Diagnosis is based on the Hunter criteria, which require:
- Patient has taken a serotonergic drug within the past 5 weeks
- Presence of one or more of the following:
Treatment Algorithm
Step 1: Discontinue Offending Agents
Step 2: Supportive Care
- Administer IV fluids for hydration 1, 3
- Provide oxygen as needed 1
- Monitor vital signs, cardiac rhythm, and oxygen saturation continuously 1
Step 3: Symptom-Specific Management
For agitation and tremor:
For moderate to severe cases:
- Administer cyproheptadine (serotonin antagonist) 1, 2
- Adult dosing: Initial 12 mg PO, followed by 4-8 mg every 6 hours as needed 4
- Pediatric dosing (2-6 years): 0.25 mg/kg/day divided into 2-3 doses, not exceeding 12 mg/day 4
- Pediatric dosing (7-14 years): 4 mg 2-3 times daily, not exceeding 16 mg/day 4
Step 4: Management of Severe Cases
- For temperature >41°C:
Severity Classification and Treatment Approach
Mild Serotonin Syndrome
- Features: Mild tremor, hyperreflexia, mild agitation
- Management: Discontinuation of serotonergic agents and supportive care 6, 2
Moderate Serotonin Syndrome
- Features: Tachycardia, hypertension, hyperthermia (38-40°C), clonus, hyperreflexia, agitation
- Management: Benzodiazepines plus cyproheptadine, inpatient monitoring 1, 2
Severe Serotonin Syndrome
- Features: Temperature >40°C, severe rigidity, autonomic instability, delirium
- Management: ICU admission, possible intubation, neuromuscular paralysis, aggressive cooling 1, 5
Important Considerations
- Serotonin syndrome can rapidly progress from mild to life-threatening, requiring close monitoring 3
- Without proper treatment, mortality can be as high as 11%, primarily due to complications like rhabdomyolysis, renal failure, and DIC 1
- Cyproheptadine may not be available in IV form, making administration challenging in severe cases with altered mental status 7
- Avoid physical restraints when possible as they may worsen hyperthermia and rhabdomyolysis 5
Common Pitfalls to Avoid
- Misdiagnosing serotonin syndrome as neuroleptic malignant syndrome, malignant hyperthermia, or anticholinergic toxicity 5
- Continuing any serotonergic medications, even those not initially suspected 3
- Administering antipyretics alone for hyperthermia (they don't address the underlying mechanism) 7
- Failing to recognize that serotonin syndrome can occur with therapeutic doses of single agents, not just overdoses or drug combinations 6
- Delaying cyproheptadine administration in moderate to severe cases 2
With prompt recognition and appropriate management, most cases of serotonin syndrome have a favorable prognosis 6, 2.